Yu-Han Kao

5PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 09, 2026
Publisher Correction: Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice.

|May 19, 2026
Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice.

|Jan 28, 2026
Treatment Patterns, Clinical Outcomes, Health Care Resource Use, and Costs in Older Adults with Malignant Pleural Mesothelioma in the United States, 2007-2020.

Himani Aggarwal, Ashwini Arunachalam, Jae Min

|Nov 19, 2025
Trends in initial primary treatment approach and biomarker testing across social determinants of health in early-stage non-small cell lung cancer.

Xiaohan Hu, Yu-Han Kao, Ashwini Arunachalam

|Oct 17, 2025
5-year real-world outcomes with first-line pembrolizumab plus chemotherapy in advanced/metastatic NSCLC.

Stephen V Liu, Riddhi A Babel, Yu-Han Kao

Pageof 1

Frequent Collaborators

3 joint publications

Xiaohan Hu

2 joint publications

Chethan Ramamurthy

2 joint publications

Ashwini Arunachalam

2 joint publications

Jennifer Stuart